StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX)
Equities research analysts at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of DURECT in a research note on Thursday, November 14th. […]
More Stories
Boulder Attack Suspect’s Family Taken Into Federal Custody; Deportation May Be Imminent
By Janice Hisle The White House says the family of the suspect in Sunday’s terror attack in Boulder, Colorado, might...
US Sends Letters to Trade Partners to Seek ‘Best Offers’ by June 4
By Austin Alonzo The U.S. trade representative is sending “friendly reminders” that a trade negotiation deadline is coming due, White...
Dollar General Beats Trend, Lifts Guidance as Higher-Income Shoppers Seek Bargains
By Panos Mourdoukoutas Shaking off concerns raised by several retailers over a potential shortfall in sales and earnings, Dollar General...
Super Bowl Champs Ronald Darby, David Andrews Top List of High-Profile NFL Retirements
By John Rigolizzo Super Bowl Champion cornerback Ronald Darby headlines a list of high-profile NFL retirements. The Houston Texans placed...
Job Openings Unexpectedly Jump to 7.39 Million in April: JOLTS
By Andrew Moran Employment vacancies unexpectedly rose in April, reaffirming the health of the U.S. labor market. According to the...
Job Openings Unexpectedly Jump to 7.39 Million in April: JOLTS
By Andrew Moran Employment vacancies unexpectedly rose in April, reaffirming the health of the U.S. labor market. According to the...